Precision BioSciences Deploys Skyland PIMS Life Science Process Data Management Software In Support Of Its Manufacturing Operations

Precision BioSciences is a clinical-stage biotechnology company developing allogeneic CAR T and in vivo gene correction therapies. With an eye toward therapeutic applications, the company’s ARCUS® genome editing platform has the potential to deliver safer, more specific genetic edits. ARCUS has a naturally occurring gene editing property that shuts itself off after making a highly specific DNA edit. This built-in safety switch is a key differentiator compared to other gene editing technologies.

Learn more about PIMS and how it can meet your operational needs.